VILI and MSCs, page-6

  1. 453 Posts.
    lightbulb Created with Sketch. 48
    Anyone have any thoughts about the pricing of this if it is as successful as we are all hoping? The treatment costs for use with aGVHD is $200-$300,000. It seems beyond hope that the market would pay this much for CV treatment. Admittedly there would be some huge economies of scale savings to be had with the expanded product uses but would it mean the pricing for aGVHD would be reduced significantly? If not, how would you prevent use of Rem-L bought at a lower price for CV treatment being used for aGVHD or is it that you need a much lower or less frequent dosage for CV treatment?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.59
Change
-0.025(1.55%)
Mkt cap ! $2.031B
Open High Low Value Volume
$1.61 $1.62 $1.57 $6.345M 3.987M

Buyers (Bids)

No. Vol. Price($)
6 44493 $1.59
 

Sellers (Offers)

Price($) Vol. No.
$1.59 4159 1
View Market Depth
Last trade - 16.10pm 08/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.